Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Orphazyme cleared to begin AIDNPC intervention study of arimoclomol in U.S.

June 8, 2016

Scientists identify two novel mutations causing type I hyperlipoproteinemia

June 7, 2016

GlaxoSmithKline discloses NAD-dependent SIRT1 activators

June 7, 2016

Protalix BioTherapeutics initiates global phase III study of PRX-102 in Fabry disease

June 7, 2016

GlaxoSmithKline patents SIRT1 activators

June 6, 2016

BGN gene defects may cause an X-linked syndromic form of severe TAAD

June 3, 2016

Grunenthal licenses European and Latin American rights to Zurampic from AstraZeneca

June 3, 2016

Phase I studies show target engagement, acute GI symptoms with NexVax2 in HLA DQ2.5 celiac disease

June 3, 2016

Alexion's ALXN-1210 awarded European orphan drug designation for PNH

June 2, 2016

Gene expression in obesity

June 2, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...